Skip to Main Content

Paper Details

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.
Pathol Res Pract
9
2020
Author NameAffiliation
Danny VespriniOdette Cancer Centre, Sunnybrook Health Sciences Centre and University of Toronto
Stanley K LiuOdette Cancer Centre, Sunnybrook Health Sciences Centre and University of Toronto
Theodorus H van der KwastUniversity of Toronto, University Health Network
Michelle R DownesUniversity of Toronto
  • 1 - 4

Datasets

Release 1.2